Header Logo

Connection

Shane Norris to Antiviral Agents

This is a "connection" page, showing publications Shane Norris has written about Antiviral Agents.
Connection Strength

0,530
  1. Direct costs of interferon-based and interferon-free direct-acting antiviral regimens for the treatment of chronic hepatitis C infection. J Viral Hepat. 2016 09; 23(9):677-86.
    View in: PubMed
    Score: 0,124
  2. The present and future disease burden of hepatitis C virus (HCV) infections with today's treatment paradigm - volume 2. J Viral Hepat. 2015 Jan; 22 Suppl 1:26-45.
    View in: PubMed
    Score: 0,114
  3. High uptake of hepatitis C virus treatment in HIV/hepatitis C virus co-infected patients attending an integrated HIV/hepatitis C virus clinic. Int J STD AIDS. 2011 Oct; 22(10):571-6.
    View in: PubMed
    Score: 0,091
  4. Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and ribavirin treatment. Mol Psychiatry. 2009 Dec; 14(12):1095-104.
    View in: PubMed
    Score: 0,072
  5. Haematological support during peg-interferon therapy for HCV-infected haemophiliacs improves virological outcomes. Haemophilia. 2007 Sep; 13(5):593-8.
    View in: PubMed
    Score: 0,068
  6. Progression of hepatitis C in the haemophiliac population in Ireland, after 30 years of infection in the pre-DAA treatment era. Haemophilia. 2017 Sep; 23(5):712-720.
    View in: PubMed
    Score: 0,034
  7. Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 2. J Viral Hepat. 2015 Jan; 22 Suppl 1:6-25.
    View in: PubMed
    Score: 0,028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.